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Abstract: Ullrich congenital muscular dystrophy (UCMD) is a severe form of muscular dystrophy
caused by the loss of function of collagen VI, a critical component of the muscle-tendon matrix.
Magnetic resonance imaging of UCMD patients’ muscles shows a peculiar rim of abnormal signal
at the periphery of each muscle, and a relative sparing of the internal part. The mechanism/s
involved in the early fat substitution of muscle fiber at the periphery of muscles remain elusive.
We studied a muscle biopsy of the rectus femoris/deep fascia (DF) of a 3-year-old UCMD patient,
with a homozygous mutation in the COL6A2 gene. By immunohistochemical and ultrastructural
analysis, we found a marked fatty infiltration at the interface of the muscle with the epimysium/DF
and an atrophic phenotype, primarily in fast-twitch fibers, which has never been reported before. An
unexpected finding was the widespread increase of interstitial cells with long cytoplasmic processes,
consistent with the telocyte phenotype. Our study documents for the first time in a muscle biopsy the
peculiar pattern of outside-in muscle degeneration followed by fat substitution as already shown by
muscle imaging, and an increase of telocytes in the interstitium of the deep fascia, which highlights a
potential involvement of this structure in the pathogenesis of UCMD.
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1. Introduction
Collagen VI is a microfibrillar collagen expressed in the matrix of most tissues. The
best-characterized and most widely expressed form of collagen VI is the [α1, α2, α3]
heterotrimer [1]. The α5 and α6 chains are homologues of the α3 chain, but display
a more restricted and differential distribution pattern [2,3]. Ultrastructurally, collagen
VI forms a network of beaded filaments anchored to the cell surface [4]. By interacting
with cell membrane receptors and extracellular components, collagen VI fibrils form a
network that connects the cell cytoskeleton to the extracellular environment [1,5]. The
role of collagen VI is particularly relevant for muscle-tendon unit function. The muscletendon unit involves the connection between the muscles and tendons, through which
contractile forces are generated and transmitted [6]. The muscular/deep fascia (DF), the
connective tissue sheath surrounding skeletal muscle, contributes to the transmission of
muscular force between adjacent synergistic muscles [7,8]. A detailed morphological study
of the DF has been reported in adult subjects [9], but a description of the DF in children
is still lacking. In skeletal muscle, collagen VI localizes in the basement of muscle fibers
and blood vessels and in the interstitium (epimysium, perimysium, and endomysium),
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anchoring the interstitial matrix. In tendons, in addition to interfibrillar distribution,
collagen VI is enriched in the pericellular matrix of tenocytes, where it regulates critical
cellular functions by interacting with cell membrane receptors and extracellular matrix
proteins [10]. Although poorly documented, collagen VI has been observed in the muscular
fascia [11], likely contributing to the general role of the extracellular matrix (ECM) in
providing resistance to tension and stretch, which commonly occurs in the fascial system.
In addition to its mechanical/structural role, collagen VI regulates a variety of cellular
functions including proliferation, migration, differentiation, autophagy, and stemness
maintenance [1].
Mutations in genes encoding the α1, α2, and α3 chains of collagen VI cause several
forms of muscular dystrophy, namely, Ullrich congenital muscular dystrophy (UCMD
[MIM 254090]), Bethlem myopathy (BM [MIM 158810]), and myosclerosis myopathy (MM
[MIM 255600]) [12]. UCMD represents the most severe form. It is characterized by congenital muscle weakness with axial and proximal joint contractures and coexisting distal
joint hypermobility [12]. The presentation is usually at birth, with hypotonia, congenital
hip dislocation, prominent calcanei, and a transient kyphotic deformity. Motor milestones
are delayed, and most children never acquire the ability to walk independently [12]. Follicular hyperkeratosis over the extensor surfaces of upper and lower limbs, keloids, and
cigarette paper scar formation are common. BM and MM display a distinct and less-severe
phenotype [12]. Prevalence is estimated at 0.77 in 100,000 for BM and 0.13 in 100,000 for
UCMD [13].
Muscle biopsies from UCMD patients show a complete or partial reduction of collagen VI [14], while in BM patients the protein pattern may be normal [15] or moderately
reduced [16], depending on the mode of inheritance of mutation (dominant vs. recessive,
respectively). In UCMD patients with partial deficiency, there is a specific collagen VI
reduction in the basement membrane of muscle fibers and blood vessels. The absence
of collagen VI in the basement membrane affects the anchorage of muscle fibers to the
interstitium, as demonstrated by the electron microscope observation of an empty space
between the basal lamina and the endomysial matrix [17]. Collagen VI is mainly produced
by fibroblasts resident in the tissue [18]. Cultured skin fibroblasts are usually helpful for
studies of collagen VI mRNA and protein synthesis, instead, the analysis of skin biopsies is
not always informative in patients with partial deficiency, as collagen VI may be expressed
at normal levels [19].
A distinctive feature of collagen VI-related myopathies is provided by muscle imaging.
In patients with BM, we have observed by muscle computed tomography (CT) that the rectus femoris and vastus lateralis in particular present early fat substitution at their periphery,
with a long sparing of the central part [20], and that the same pattern was also present in
UCMD [15]. This peculiar pattern of outside–in muscle degeneration followed by fat substitution has been subsequently confirmed with different muscle imaging techniques [21–26].
These alterations represent a unique feature of collagen VI-related myopathies and are
predictive of mutations in collagen VI genes.
Regarding the pathogenesis of collagen VI-related myopathies, critical events are
mitochondrial dysfunction due to inappropriate opening of the mitochondrial permeability transition pore [27] and inadequate removal of altered mitochondria by defective
autophagy [28], as demonstrated in collagen VI-deficient mice [27,28], zebrafish [29], and
in UCMD and BM patients [30,31].
Assuming that the defect of collagen VI is present throughout the muscle, it remains
to be explained why the external fibers, in contact with the DF, rapidly degenerate while
internal ones are protected from its damaging effect. This may suggest that fascia, mechanical stress and/or increase in metabolic demand stress are directly responsible for the
degenerative process, possibly opening new therapeutic or conservative treatment options.
To our knowledge, a study of early changes occurring at the muscle perifascicular area
as detected by CT [15,20], magnetic resonance imaging (MRI) [32], and ultrasound (US) [21],
has never been reported. We studied the rectus femoris/DF biopsy of a 3-year-old UCMD

Int. J. Environ. Res. Public Health 2022, 19, 1252

3 of 13

patient. We found fatty proliferation at the interface of the muscle with the epimysium/DF,
an atrophic phenotype primarily in fast-twitch fibers and proliferation of telocytes, changes
never before reported in UCMD muscle biopsies.
2. Materials and Methods
Biopsies. We obtained muscle biopsies of the rectus femoris/DF in a 3-year-old child
with UCMD with an homozygous mutation in COL6A2 (c.2572C > T) [33], in a 4-year-old
non-dystrophic patient undergoing surgical treatment for open fracture of the femur, and in
a 2-year-old patient with Duchenne muscular dystrophy (DMD) with a nonsense mutation
of exon 70 (c.10108C > T [p.R3370X]). The UCMD patient and the non-dystrophic control
both had a normal creatine kinase level, while the disease control had a very high CK, as
expected in Duchenne muscular dystrophy. Informed consent for participation in the study
was obtained from the parents of the children. The study was conducted in accordance
with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee
of the Rizzoli Orthopedic Institute (CE 0007151).
Immunofluorescence study. Seven-micron-thick frozen sections were incubated with
primary anti-collagen VI (Millipore, Burlington, MA, USA), anti-collagen I (Abcam, Cambridge, UK), anti-perilipin (Santa Cruz, Dallas, TX, USA), anti-developmental, anti-neonatal,
fast (Leica, Wetzlar, Germany) and slow myosin heavy chain (Santa Cruz, Dallas, TX, USA),
anti-CD34 (Biolegend, San Diego, CA, USA), and anti-nidogen (Millipore, Burlington,
MA, USA) antibodies and incubated with FITC, TRITC, or CY5-conjugated anti-mouse or
anti-rabbit secondary antibodies (DAKO, Glostrup, Denmark). FITC-conjugated phalloidin
(Sigma, St. Louis, MO, USA) was used for the filamentous actin staining of myofibers. Cell
nuclei were stained with 1 µg/mL DAPI (Sigma-Aldrich, St. Louis, MO, USA). Samples
were mounted with an anti-fading reagent (Molecular Probes, Eugene, OR, USA) and
observed with a Nikon epifluorescence microscope.
Transmission electron microscopy. Rectus femoris muscle fragments were fixed with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer and 1% osmium tetroxide and embedded in
Epon812 epoxy resin, following standard procedures. Semithin sections were stained with
toluidine blue. Ultrathin sections were counterstained with uranyl acetate and lead citrate
and observed with a JEOL JEM-1011 transmission electron microscope operated at 100 kV.
3. Results
Muscle magnetic resonance of the thigh in the UCMD patient at the age of 6 years
showed a rim of fat tissue in the vastus lateralis and rectus femoris, as indicated by an area
of high signal density closely associated to the peripheral fascia. In addition, the rectus
femoris showed the typical high-signal area surrounding the central fascia (“central shadow
sign”). A central part of relative muscle substitution sparing was present in the vastus
lateralis (“sandwich sign”) and in the rectus femoris with a “U” pattern (Figure 1A,B).
In the UCMD patient, a diagnostic biopsy was obtained from the rectus femoris/DF
when he was 3 years old. The morphological analysis showed a dystrophic pattern, characterized by fiber size variability, internal nuclei, increased endomysial and perimysial
fibrosis, and a marked fatty infiltration at the interface of muscle with the epimysium/DF
(Figure 2A). The DF displayed the typical fibrous organization characterized by undulated
collagen fibers (Figure 2A), as also confirmed by immunofluorescence analysis with an
antibody against anti-collagen I, a main component of the DF matrix (Figure S1A).
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To better characterize the peculiar fatty infiltration at the muscle/DF interface, we
checked for the expression of perilipin, an adipocyte-specific lipid-associated protein
(Figure 2B,C). The immunofluorescence analysis confirmed the marked fatty infiltration
at the muscle/DF interface (Figure 2B,C). By contrast, adipose cells were absent at the
interface of rectus femoris/DF biopsies from a non-dystrophic control (Figure 2B) and a
DMD patient (Figure 2C).
The study of developmental (Figure S1B) and neonatal (Figure S1C) myosin heavy
chains in the UCMD biopsy showed the presence of small immature fibers; however,
only rare fibers expressed the developmental isoform. Fast and slow myosin isoform
immunohistochemistry excluded the presence of fiber type grouping and revealed the
atrophic phenotype, primarily in fast-twitch fibers (Figure 2D).
The expression and distribution of collagen VI was studied by double labeling with
an anti-nidogen antibody, a component of the basement membrane of muscle fibers and
blood vessels. In the UCMD biopsy, collagen VI was reduced in the basement membrane
of muscle fibers and accumulated in the interstitium, a pattern typical of UCMD patients’
muscles with partial deficiency (Figure 2E). By contrast, a non-dystrophic control showed a
continuous collagen VI signal around muscle fibers, perfectly matching with the nidogen
staining (Figure 2E). In the DF of the UCMD patient, collagen VI appeared mildly reduced
and displayed an undulated pattern compared with the intense and diffuse pattern of the
non-dystrophic control (Figure 2F).
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Figure 2. Morphological changes in the UCMD muscle/DF biopsy. (A) Hematoxylin and eosin
Figure on
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affected by Duchenne muscular dystrophy (DMD). Note the presence of an empty space (F) between
the DF and the muscle fibers (M) in the UCMD biopsy, suggestive of fat tissue proliferation. Fatty
infiltration is not evident at the muscle/DF interface in both DMD and non-dystrophic control (CTRL)
biopsy; DMD biopsy displays the characteristic hypercontracted fibers (asterisk). Scale bar, 50 µm.
(B) Immunofluorescence analysis of dystrophin (green) and perilipin (red) on muscle sections of the
non-dystrophic control (CTRL, upper panel) and the UCMD patient (UCMD, lower panel). Fatty
infiltrate, as detected by perilipin, is prominent at the muscle (M)/DF interface in the UCMD biopsy,
while it is absent in the analogue region of the non-dystrophic control. Nuclear staining, DAPI. DF,
deep fascia. Scale bar, 50 µm. (C) Anti-perilipin (red) immunostaining on DMD and UCMD muscle
sections. Note the differential distribution of adipose cells (perilipin-positive) which appears mainly
subfascial in UCMD, and perimysial in the DMD patient (arrow). Muscle fibers are marked with
FITC-conjugated phalloidin (green). Nuclear staining, DAPI. Scale bar, 50 µm. (D) Fast (MHC-fast)
and slow (MHC-slow) myosin heavy chain staining in UCMD muscle biopsy showing the atrophic
phenotype primarily in fast-twitch fibers. Muscle fibers are labeled with FITC-conjugated phalloidin
(green). Nuclear staining, DAPI. Scale bar, 50 µm. (E) Immunofluorescence analysis of collagen VI
(COL6, green) and the basement membrane component nidogen (nidog, red), and superimposed
images (merge) on non-dystrophic control (CTRL) and UCMD patient (UCMD). Note the presence
of a continuous signal at the basement membrane of myofibers of the non-dystrophic control with
anti-collagen VI antibody, perfectly merging with nidogen staining (orange signal in merge image).
UCMD muscle displays an accumulation of collagen VI in the interstitium (asterisk) and a marked
reduction in the basement membrane of muscle fibers, as indicated by the red signal in the merge
image. Inserts show a detail of the muscle fiber basement membrane of the respective images.
Nuclear staining, DAPI. Scale bar, 30 µm. (F) Low magnification of collagen VI immunolabeling
on cross sections of muscle/DF biopsies showing an undulating pattern in the DF in the UCMD
patient (UCMD), as compared with the diffuse and more intense pattern in the non-dystrophic control.
Nuclear staining, DAPI. Scale bar, 50 µm.

For a better understanding of the morphological alterations, a fragment of each biopsy
was processed for transmission electron microscopy analysis. Semithin cross sections of the
UCMD biopsy confirmed the presence of ectopic fatty infiltration at the interface of muscle
with the DF (Figure 3A). Accordingly, with the immunohistochemical analysis, adipose cells
were absent in the analogue area of the DMD patient (Figure 3A). At the ultrastructural level,
the DF of the UCMD patient appeared to be composed of a fibrous matrix with typically
undulated collagen fibers, displaying normal size and morphology (Figure 3B). In addition
to fibroblasts, which represent the main cell type in normal fascia, we noted numerous
telocytes, stromal cells distinct from fibroblasts for their long moniliform cytoplasmic
processes (telopodes) (Figure 3B,C); telopodes formed homocellular (telocyte-to-telocyte)
contacts, featuring interdigitations and adherens junctions (Figure 3C). Telocytes were also
frequently detected in the muscle interstitium, in close relationship with muscle fibers,
adipocytes (Figure 4A), and blood vessels (Figure S1D). Aspects of telopodes passing
through fragmented basal lamina and contacting the underlying muscle fiber membrane
were frequently detected (Figure 4B). The abundance of telocytes in UCMD biopsy was also
confirmed by the immunohistochemical analysis of CD34, a reliable marker for telocyte
detection in situ. To discriminate CD34-positive endothelial cells from telocytes, sections
were double-labeled with an anti-nidogen antibody, a component of the vessel basement
membrane. In agreement with ultrastructural observations, numerous CD34-positive cells
were detected in the DF and the interstitium of muscle of the UCMD patient (Figure 4D),
while in the non-dystrophic control they were less diffuse and mainly associated with blood
vessels (Figure 4C).
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Figure 3. Ultrastructural changes in UCMD muscle/DF biopsy. (A) Semithin sections of the DMD and
UCMD muscle/DF biopsies confirming the presence of ectopic fatty infiltration (F) at the interface of
muscle with the epimysium/DF)
in UCMD patient.
the other
hand, fatty
infiltration
is notsections
evidentof the DMD
Figure 3. Ultrastructural
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muscle/DF
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in the muscle biopsy and
of the
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bar,confirming
50 µm. (B)
electron
microscopy
interface of muscle with the epimysium/DF) in UCMD patient. On the other hand, fatty infiltration
analysis of DF in DMD (DMD, upper panel) and UCMD (UCMD, lower panel) biopsies. In DMD
is not evident in the muscle biopsy of the DMD patient. Scale bar, 50 µm. (B) Transmission electron
sample, a fibroblast (F) with a typical elongated nucleus appears immersed in the DF matrix, mainly
constituted by collagen fibrils (C). In addition to fibroblasts (F), the UCMD DF shows several cells
with oval nuclei and long cytoplasmic processes, consistent with telocyte phenotype (T), are also
present. Moniliform (arrowhead) or enlarged (arrow) telopodes are diffuse in the UCMD DF. Scale
bar, 5 µm. (C) Digitally colored telocytes (green) showing homocellular (telocyte-to-telocyte) contacts,
such as interdigitations (right, upper panel) and adherens junctions (arrow; right, lower panel). Scale
bar, left panel, 10 µm, right panels, 800 nm.

matrix, mainly constituted by collagen fibrils (C). In addition to fibroblasts (F), the UCMD DF shows
several cells with oval nuclei and long cytoplasmic processes, consistent with telocyte phenotype
(T), are also present. Moniliform (arrowhead) or enlarged (arrow) telopodes are diffuse in the
UCMD DF. Scale bar, 5 µm. (C) Digitally colored telocytes (green) showing homocellular (telocyteto-telocyte)
contacts, such as interdigitations (right, upper panel) and adherens junctions
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Figure 4. Telocyte–muscle cell relationship in the UCMD patient’s biopsy. (A) Ultrastructural
analysis of UCMD muscle biopsy showing the presence of several telocytes (digitally colored in
green) with typical moniliform (Tm) or varicose (Tv, pink colored) telopodes within the endomysium.
Figure 4. Telocyte–muscle cell relationship in the UCMD patient’s biopsy. (A) Ultrastructural
Muscle fibers (M) and adipose cells (F) appear almost completely wrapped by telopodes. Scale
analysis of UCMD muscle biopsy showing the presence of several telocytes (digitally colored in
bar, 1 µm. (B) On the left, a representative area particularly enriched in telocytes (green). In the
green) with typical moniliform (Tm) or varicose (Tv, pink colored) telopodes within the
area enclosed by the box, three telopodes (1–3) appear in close contact with a tract of sarcolemma
endomysium. Muscle fibers (M) and adipose cells (F) appear almost completely wrapped by
devoid of basal lamina (enlargement in the right panel). N, nucleus; bl, basal lamina. Scale bar,
telopodes. Scale bar, 1 µm. (B) On the left, a representative area particularly enriched in telocytes
1 µm. (C) Immunohistochemical analysis of the basement membrane component nidogen (nidog)
(green). In the area enclosed by the box, three telopodes (1–3) appear in close contact with a tract of
and CD34 (magenta in the merge panel) in the biopsy of the non-dystrophic control. Nidogen staining
sarcolemma devoid of basal lamina (enlargement in the right panel). N, nucleus; bl, basal lamina.
delineates the basement membrane of muscle fibers (M) and capillary vessels (arrows). Most of the
Scale bar, 1 µm. (C) Immunohistochemical analysis of the basement membrane component nidogen
CD34-positive cells are represented by vascular endothelial cells, as suggested by the localization in
(nidog) and CD34 (magenta in the merge panel) in the biopsy of the non-dystrophic control.
the vessel wall. Scale bar, 50 µm. (D) Immunohistochemical analysis of CD34 and nidogen (nidog) in
Nidogen staining delineates the basement membrane of muscle fibers (M) and capillary vessels
the UCMD biopsy. In addition to endothelial cells (arrows), CD34 identifies several interstitial cells in
(arrows). Most of the CD34-positive cells are represented by vascular endothelial cells, as suggested
the DF, where a reticular network is formed, and between muscle fibers (M). Scale bar, 50 µm.
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4. Discussion
The principal aim of our study was to shed light on the mechanism(s) leading to
the loss of muscle fibers at the periphery of muscle, a pathognomonic sign of collagen
VI-related myopathies.
We report that the histopathological changes occurring at the periphery of the rectus
femoris muscle of a 3-year-old UCMD patient are consistent with an active dystrophic
process, as indicated by the presence of fatty infiltration. This pattern works perfectly
with the fat substitution of peripheral muscle fibers documented by muscle imaging in
this patient with UCMD and in additional patients reported in our study [15] and other
studies [21–23,25,26,32]. Previous studies on muscle biopsies from UCMD patients reported
a variable histopathological pattern, ranging from mild myopathic [34,35] to dystrophic [36],
independent of patient age [35]. It is conceivable that the observed variability may be related
to the muscle or the area of biopsy sampling (peripheral vs. internal).
We found an atrophic phenotype, prevalently of fast-twitch fibers. Muscle-fiber atrophy has been described as a prevalent mechanism in biopsies obtained from patients
with UCMD; however, it was mainly observed in type I fibers [34]. A bimodal distribution
of type I fibers, one population of which was extremely atrophic [36], was also reported.
Muscle wasting can occur through multiple distinct signaling pathways, with differential
sensitivity levels between selective skeletal-muscle-fiber subtypes. Fast-twitch glycolytic
fibers are more sensitive to a variety of conditions related to different signaling pathways,
including autophagy [37]. It is interesting that Col6a1-/- mice and patients display reduced
autophagy flux [28]; reactivation of autophagy is protective against muscle mass loss in
knock-out mice [28], while in BM and UCMD patients it improves the mitochondrial performance and the rate of apoptosis, downstream consequences of the autophagy defect [31].
On the other hand, the involvement of type II fibers as early changes in UCMD muscle
could be consistent with the reported prevalence of type I fibers [36], which, moreover,
are less sensitive to autophagy deficiency [37]. Slow and fast-twitch fibers display distinct
mechanical behavior, metabolism, and signaling pathways [38]. Physical exercise has a
detrimental effect on Col6a1-/- animals and leads to a muscle pathology closer to the human
UCMD condition [38]. This is because physical exercise stimulates autophagy in muscles of
wild-type mice. However, this stimulus does not trigger autophagy in collagen VI-deficient
mice, and it has detrimental effects on Col6a1-/- muscles [38]. Thus, the inability to properly activate autophagy in diseased muscles under conditions of intense workload and
increased need for energy sources may lead to deterioration of muscle-fiber defects.
Regeneration was evident in the muscle biopsy of our UCMD patient, as indicated
by the presence of small immature fibers positive to neonatal myosin heavy chains. However, rare fibers expressed the developmental isoform, suggesting a block of the regenerative/maturation process. This observation is consistent with previous works on UCMD
biopsies, which reported prominent [35,36] but abnormal [36] regeneration in UCMD muscle biopsies. Lack of collagen VI in Col6a1-/- mice causes impaired muscle regeneration
and reduced satellite cell self-renewal capability after injury [39]. The mechanism underlying the defective regeneration in collagen VI-deficient mice and patients is still under
investigation. However, it is interesting to note that in two pilot trials with cyclosporine
A (CsA) in UCMD patients, aimed at the correction of mitochondrial dysfunction [40,41],
we noted an increase of developmental myosin heavy chain-positive fibers, which are
rare in patients under basal conditions. This suggests that the recovery of mitochondrial
function may have a positive effect on regenerative potential. In addition, CsA treatment,
by activating autophagy [28], may contribute to the recovery of a critical mechanism for
muscle regeneration/differentiation [42,43].
An unexpected observation in our study was the diffuse and significant increase of
cells with morphological and ultrastructural features of telocytes. Telocytes were closely
associated with adipose, vessel, and muscle cells. Ultrastructurally distinguishable from
other interstitial cells because very long cytoplasmic processes (telopodes) were present,
telocytes formed a complex network establishing homocellular and heterocellular junctional
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complexes. The increase was relative to the biopsies of a non-dystrophic control and of a
DMD patient, which displayed occasional interstitial telocytes. It is interesting to note that
despite the number of ultrastructural studies on muscle biopsies of UCMD patients, an
increase of telocytes has never been reported, suggesting a possible specific involvement
at the interface of muscle with the epimysium/fascia. Telocytes were also increased in
the matrix of the DF of the UCMD patient. Recently, telocytes have been reported in the
human fascia lata [44]; however, their distribution and potential role in this tissue remain
elusive. In other organs, telocytes contribute to tissue organization during development
and maintain postnatal tissue/organ structural integrity and function [45]. Telocytes play
an important role in cell–cell communication with adjacent cells within the tissue via direct
patterns or through indirect ways, such as cellular junctions, the production of multi-factors,
and extracellular vesicles [45,46]. In the context of skeletal muscle, an increase in telocytes
has been reported in post-injury models in rodents, and particularly in exercise-induced
remodeling after acute myocardial infarction [47]. In an ex vivo model of muscle injury,
telocytes may activate and regulate satellite activity by invading the satellite cell niche with
their telopodes through a fragmented basal lamina and contacting the underlying activated
satellite cells [48]. Similar aspects were found in the biopsy of our UCMD patient. In fact,
we found telopodes in direct contact with the muscle sarcolemma in areas with interrupted
basement membrane.
These observations support the importance of these cells in differentiation and regenerative processes. However, it remains unclear why telocytes have never been reported/noted
in other muscle-degenerative diseases characterized by active regeneration. We also did
not notice an increase of these cells in the biopsy of the DMD patient, though DMD is a
muscular disorder with regeneration as a prominent characteristic [49]. Telocytes were discovered recently, and their role with respect to specific pathomechanisms remains unknown.
Telocytes may influence neighboring cells by secreting various signaling molecules [45].
Determination of whether the deficiency of collagen VI affects telocyte behavior/function
requires further study.
5. Conclusions
The muscle biopsy/DF of the rectus femoris matches the peculiar pattern of outside–in
muscle degeneration followed by fat substitution documented by muscle imaging. The
changes at the interface of the muscle with the epimysium/DF are characterized by an
early demise of the fast-twitch fibers and a marked ectopic fatty infiltration. One possible
hypothesis is that peripheral muscle fibers, subjected to a more intense workload and a
greater need for energy sources, are affected earlier by mitochondrial dysfunction associated
with defective autophagy, the two pathogenetic mechanisms of collagen VI. In addition,
the increase of telocytes in UCMD deep fascia may be the consequence of an active tissueremodeling process, highlighting a possible unrecognized involvement/role of the DF in
UCMD pathogenesis.
Supplementary Materials: The following supporting information can be downloaded at: https:
//www.mdpi.com/article/10.3390/ijerph19031252/s1, Figure S1: A. Immunofluorescence analysis
of collagen I on cross sections of muscle/deep fascia biopsy from a non-dystrophic control (CTRL),
a Duchenne muscular dystrophy patient (DMD), and the UCMD patient (UCMD). In all samples,
deep fascia (DF) appears as a fibrous sheet covering the muscle (M). Nuclei, DAPI. Scale bar, 50 m.
B. Immunohistochemical analysis of the sarcolemmal component dystrophin (dys, green) and developmental myosin heavy chain (MHC-d, red) on muscle sections of the UCMD patient. Despite
the presence of several hypotrophic fibers, only one show regeneration features (arrow). Nuclei,
DAPI. Scale bar, 50 m. C. Immunohistochemical analysis of the basement membrane component
nidogen (nidog, red) and neonatal myosin heavy chain (MHC-d, green) on muscle sections of the
UCMD patient showing some small regenerating muscle cells. Nuclei, DAPI. Scale bar, 50 m. D.
Ultrastructural analysis of UCMD muscle biopsy showing the presence of several telocytes (digitally
colored in green) in the endomysium. A capillary vessel (Cv) appear almost completely wrapped by
telocytes cytoplasmic processes (telopodes, Tp). Scale bar, 1 m.
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